Melatonin does not protect against SARS-CoV-2
HIV Treatment Bulletin
; 23:28-28, 2022.
Article
in English
| Africa Wide Information | ID: covidwho-2092334
ABSTRACT
WATERLIT Results from a randomised study reported no benefit of daily oral melatonin (2 mg QD) for 12 weeks compared to placebo as prophylaxis against SARS-CoV-2 in 314 Spanish health workers
Search on Google
Collection:
Databases of international organizations
Database:
Africa Wide Information
Language:
English
Journal:
HIV Treatment Bulletin
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS